Insider Trading February 24, 2026

Oregon Community Foundation Disposes of 7,414 Jewett-Cameron Shares in Late-February Trades

Small sell-off by a 10% holder comes as Jewett-Cameron reports weaker Q4 2025 results and its stock sits near a one-year low

By Maya Rios JCTC
Oregon Community Foundation Disposes of 7,414 Jewett-Cameron Shares in Late-February Trades
JCTC

Oregon Community Foundation, which holds roughly ten percent of Jewett-Cameron Trading Co LTD, executed two stock sales totaling 7,414 shares on February 23 and 24, 2026, raising $13,363. The transactions reduced the foundation's stake to 778,545 shares. The trades occurred against a backdrop of a difficult fourth quarter for Jewett-Cameron, which reported EPS of -0.64 and revenue of $10.37 million for 2025 Q4 while its share price remains near a 52-week low.

Key Points

  • The Oregon Community Foundation sold 7,414 shares of Jewett-Cameron (JCTC) common stock on February 23-24, 2026, raising $13,363.
  • After the two transactions, the foundation's holdings decreased to 778,545 shares; transactions were signed by Erica D. Daley, CFO and COO.
  • Jewett-Cameron reported a difficult Q4 2025 with EPS of -0.64 and revenue of $10.37 million, and its stock is trading near a 52-week low, down 61% over the past year - impacting equity market participants and investors monitoring corporate earnings.

Oregon Community Foundation, a holder of approximately 10% of Jewett-Cameron Trading Co LTD common stock (NASDAQ: JCTC), sold a total of 7,414 shares across two transactions on February 23 and February 24, 2026. The combined proceeds from those trades amounted to $13,363.

On February 23, the foundation sold 3,550 shares at $1.804 per share. After that sale, the foundation's position stood at 782,409 shares. The following day, February 24, an additional 3,864 shares were sold at $1.8011 per share, reducing the foundation's holdings to 778,545 shares. The transactions were executed in two separate trades and were signed on behalf of the foundation by Erica D. Daley, Chief Financial and Operations Officer.

These insider sales coincided with a period of depressed market pricing for JCTC. The stock was trading close to its 52-week low of $1.66 and has declined 61% over the last year. The share-price context and the foundation's incremental reduction in holdings are notable to investors tracking insider activity and company ownership trends.


Company financials and recent performance

In corporate results that preceded the trades, Jewett-Cameron Trading Company reported a challenging fourth quarter for 2025. The firm posted earnings per share of -0.64 and revenue of $10.37 million for the quarter. Both figures fell short of expectations and represented a significant decline year over year. The weak quarterly performance has been highlighted by investors assessing the firm’s current financial position and near-term outlook.

Revenue and EPS are central metrics for stakeholders seeking insight into the company’s financial health. The disappointing results for Q4 2025 have contributed to scrutiny of management’s strategy and operational execution in the recent period.


What this means for market participants

The foundation’s two modest transactions do not eliminate its position as a substantial shareholder, but they do reflect a reduction in ownership. Market participants reviewing company filings and insider transactions will consider both the size of the remaining stake and the context of the company’s quarterly earnings when forming assessments. The company’s recent financial report and the stock’s proximity to its 52-week low are pieces of information investors will weigh alongside any future disclosures from the company.

Additional details on ownership changes, executive signatories, and quarterly disclosures are available from the company’s filings. Where public filings are limited, investors may find the available data constraining and will need to monitor subsequent reports for further clarity.

Risks

  • Market risk: JCTC shares are trading near a 52-week low and have fallen 61% year over year, indicating elevated market price volatility for shareholders.
  • Operational and financial risk: The company reported negative earnings per share and weaker revenue in Q4 2025, which raises uncertainty around near-term financial performance.
  • Information risk: Limited public detail beyond the quarterly results and the disclosed insider transactions may constrain stakeholders seeking fuller clarity on company strategy and recovery prospects.

More from Insider Trading

North Run Strategic Sells $9.1M of LightPath Class A Shares After Preferred Conversion Feb 24, 2026 Pentwater Capital Increases Stake in Avis Budget with $40.06 Million Share Purchase Feb 24, 2026 Caribou Biosciences CLO Sells Shares to Cover RSU Taxes as Company Sees Recent Price Gains Feb 24, 2026 Fold Holdings CFO completes RSU-related share sale as company outlines bitcoin service overhaul Feb 24, 2026 Natural Alternatives International CEO Makes Small Open-Market Purchases Amid Credit Waiver Feb 24, 2026